CIK: 1222037 - Address: Aimmune Therapeutics, Inc., 8000 Marina Boulevard, Suite 300, Brisbane, CA 94005-1884
13 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/5/20 21:20
10/2/20
AIMTAimmune Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdelman Daniel C MdCAOChief MeM.d40011.4503512164D
1/3/20 20:41
1/2/20
AIMTAimmune Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdelman Daniel C MdCAOChief MeM.d39319.63020999%21D
1/3/20 20:41
1/2/20
AIMTAimmune Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdelman Daniel C MdCAOChief MeS.d-70035.000-20-4821D
12/11/19 17:50
12/9/19
AIMTAimmune Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdelman Daniel C MdCAOChief MeM.d22911.45020999%21D
12/11/19 17:50
12/9/19
AIMTAimmune Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdelman Daniel C MdCAOChief MeS.d-60130.040-20-4821D
1/16/18 18:05
1/12/18
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsAdelman Daniel C MdCAOChief MeM.dm42011.450370D
1/16/18 18:05
1/12/18
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsAdelman Daniel C MdCAOChief MeS.dm-1,46940.000-37-1000D
12/29/17 17:26
12/27/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsAdelman Daniel C MdCAOChief MeM.d3811.45030D
12/29/17 17:26
12/27/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsAdelman Daniel C MdCAOChief MeS.d-13140.000-3-1000D
10/25/17 16:05
10/23/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsAdelman Daniel C MdCAOChief MeM.d11511.450100D
10/25/17 16:05
10/23/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsAdelman Daniel C MdCAOChief MeS.d-34134.060-10-1000D
9/27/17 16:06
9/25/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsAdelman Daniel C MdCAOChief MeM.d11511.450100D
9/27/17 16:06
9/25/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsAdelman Daniel C MdCAOChief MeS.d-25025.000-10-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact